BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15289103)

  • 1. Crystal structures of novel non-peptidic, non-zinc chelating inhibitors bound to MMP-12.
    Morales R; Perrier S; Florent JM; Beltra J; Dufour S; De Mendez I; Manceau P; Tertre A; Moreau F; Compere D; Dublanchet AC; O'Gara M
    J Mol Biol; 2004 Aug; 341(4):1063-76. PubMed ID: 15289103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor.
    Nar H; Werle K; Bauer MM; Dollinger H; Jung B
    J Mol Biol; 2001 Sep; 312(4):743-51. PubMed ID: 11575929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.
    Kiyama R; Tamura Y; Watanabe F; Tsuzuki H; Ohtani M; Yodo M
    J Med Chem; 1999 May; 42(10):1723-38. PubMed ID: 10346925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors.
    Dublanchet AC; Ducrot P; Andrianjara C; O'Gara M; Morales R; Compère D; Denis A; Blais S; Cluzeau P; Courté K; Hamon J; Moreau F; Prunet ML; Tertre A
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3787-90. PubMed ID: 16002291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extra binding region induced by non-zinc chelating inhibitors into the S1' subsite of matrix metalloproteinase 8 (MMP-8).
    Pochetti G; Montanari R; Gege C; Chevrier C; Taveras AG; Mazza F
    J Med Chem; 2009 Feb; 52(4):1040-9. PubMed ID: 19173605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The crystal structures of human alpha-thrombin complexed with active site-directed diamino benzo[b]thiophene derivatives: a binding mode for a structurally novel class of inhibitors.
    Chirgadze NY; Sall DJ; Briggs SL; Clawson DK; Zhang M; Smith GF; Schevitz RW
    Protein Sci; 2000 Jan; 9(1):29-36. PubMed ID: 10739244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of human MMP9 in complex with a reverse hydroxamate inhibitor.
    Rowsell S; Hawtin P; Minshull CA; Jepson H; Brockbank SM; Barratt DG; Slater AM; McPheat WL; Waterson D; Henney AM; Pauptit RA
    J Mol Biol; 2002 May; 319(1):173-81. PubMed ID: 12051944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of the stromelysin-3 (MMP-11) catalytic domain complexed with a phosphinic inhibitor mimicking the transition-state.
    Gall AL; Ruff M; Kannan R; Cuniasse P; Yiotakis A; Dive V; Rio MC; Basset P; Moras D
    J Mol Biol; 2001 Mar; 307(2):577-86. PubMed ID: 11254383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution structures of stromelysin complexed to thiadiazole inhibitors.
    Stockman BJ; Waldon DJ; Gates JA; Scahill TA; Kloosterman DA; Mizsak SA; Jacobsen EJ; Belonga KL; Mitchell MA; Mao B; Petke JD; Goodman L; Powers EA; Ledbetter SR; Kaytes PS; Vogeli G; Marshall VP; Petzold GL; Poorman RA
    Protein Sci; 1998 Nov; 7(11):2281-6. PubMed ID: 9827994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for the highly selective inhibition of MMP-13.
    Engel CK; Pirard B; Schimanski S; Kirsch R; Habermann J; Klingler O; Schlotte V; Weithmann KU; Wendt KU
    Chem Biol; 2005 Feb; 12(2):181-9. PubMed ID: 15734645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Third generation of matrix metalloprotease inhibitors: Gain in selectivity by targeting the depth of the S1' cavity.
    Devel L; Czarny B; Beau F; Georgiadis D; Stura E; Dive V
    Biochimie; 2010 Nov; 92(11):1501-8. PubMed ID: 20696203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Design, synthesis and activity evaluation of novel matrix metalloproteinases inhibitors based on the structure of enzyme].
    Jia H; Guo YS; Ge YY; Wen H; Yang J; Yang XY; Du GH; Yang GZ
    Yao Xue Xue Bao; 2007 Dec; 42(12):1271-81. PubMed ID: 18338640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.
    Heim-Riether A; Taylor SJ; Liang S; Gao DA; Xiong Z; Michael August E; Collins BK; Farmer BT; Haverty K; Hill-Drzewi M; Junker HD; Mariana Margarit S; Moss N; Neumann T; Proudfoot JR; Keenan LS; Sekul R; Zhang Q; Li J; Farrow NA
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5321-4. PubMed ID: 19692239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new role for old ligands: discerning chelators for zinc metalloproteinases.
    Jacobsen FE; Lewis JA; Cohen SM
    J Am Chem Soc; 2006 Mar; 128(10):3156-7. PubMed ID: 16522091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structures of MMPs in complex with physiological and pharmacological inhibitors.
    Maskos K
    Biochimie; 2005; 87(3-4):249-63. PubMed ID: 15781312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ "click" assembly of small molecule matrix metalloprotease inhibitors containing zinc-chelating groups.
    Hu M; Li J; Yao SQ
    Org Lett; 2008 Dec; 10(24):5529-31. PubMed ID: 19053720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structures of the catalytic domain of human stromelysin-1 (MMP-3) and collagenase-3 (MMP-13) with a hydroxamic acid inhibitor SM-25453.
    Kohno T; Hochigai H; Yamashita E; Tsukihara T; Kanaoka M
    Biochem Biophys Res Commun; 2006 May; 344(1):315-22. PubMed ID: 16603129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SAR studies of non-zinc-chelating MMP-13 inhibitors: improving selectivity and metabolic stability.
    Gao DA; Xiong Z; Heim-Riether A; Amodeo L; August EM; Cao X; Ciccarelli L; Collins BK; Harrington K; Haverty K; Hill-Drzewi M; Li X; Liang S; Margarit SM; Moss N; Nagaraja N; Proudfoot J; Roman R; Schlyer S; Keenan LS; Taylor S; Wellenzohn B; Wiedenmayer D; Li J; Farrow NA
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5039-43. PubMed ID: 20675133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel matrix metalloproteinase inhibitors: generation of lead compounds by the in silico fragment-based approach.
    Takahashi K; Ikura M; Habashita H; Nishizaki M; Sugiura T; Yamamoto S; Nakatani S; Ogawa K; Ohno H; Nakai H; Toda M
    Bioorg Med Chem; 2005 Jul; 13(14):4527-43. PubMed ID: 15908222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: mode of binding in a complex with MMP-8.
    Campestre C; Agamennone M; Tortorella P; Preziuso S; Biasone A; Gavuzzo E; Pochetti G; Mazza F; Hiller O; Tschesche H; Consalvi V; Gallina C
    Bioorg Med Chem Lett; 2006 Jan; 16(1):20-4. PubMed ID: 16242329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.